US equities |
MU $1,088.00 ▲+4.06% NVDA $237.47 ▼-0.74% SNDK $1,692.42 ▲+1.92% SPCX $167.60 ▼-2.51% AMD $645.86 ▼-0.55% AAPL $336.67 ▲+0.91% TSLA $377.81 ▼-0.75% META $721.31 ▼-2.38%
FinancialContent

Latest News about Pharmather

Recent news which mentions Pharmather

PharmaTher Provides Business Highlights And Releases Audited Annual Financials
Tickers PHRRF
Tags Earnings Psychedelics Penny Stocks
From Benzinga
PharmaTher Granted Orphan Drug Designation for Life-Saving Seizure Medicine
Tags General Markets psychedelics
From Benzinga
Psychedelic Medicine Co. PharmaTher Provides Update On Pipeline And Milestones For 2022
Tickers PHRRF
Tags psychedelics Market News Clinical Study
From Benzinga
FDA Approves PharmaTher's Phase 2 Trial For Ketamine ALS Treatment
Tickers ALS PHRRF
Tags ALS Penny Stocks General
From Benzinga